FIELD: medicine, cardiosurgery. SUBSTANCE: method involves administration of anti-inflammatory agents, deaggregants and hypolipidemic preparations at the nearest postoperative period. Also, inhibitors of angiotension-converting enzyme at therapeutic dose for 12 months are prescribed additionally. EFFECT: enhanced effectiveness of prophylaxis. 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING OCCURRENCES OF RESPIRATORY DISTRESS SYNDROME OF ADULTS AND POLYORGAN INSUFFICIENCY IN CARRYING OUT CORONARY BY-PASS WITH ARTIFICIAL BLOOD CIRCULATION APPLIED | 1997 |
|
RU2138049C1 |
| METHOD OF PREDICTING RISK OF GLOMERULAR FILTRATION RATE REDUCTION AFTER AORTOCORONARY BYPASS SURGERY ON WORKING HEART | 2013 |
|
RU2553366C2 |
| METHOD FOR PREDICTION OF AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC HEART DISEASE WHO UNDERWENT AORTOCORONARY BYPASS SURGERY | 2018 |
|
RU2688241C1 |
| METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE FOLLOWING CORONARY ARTERY BYPASS SURGERY | 2011 |
|
RU2466395C1 |
| METHOD FOR FORECASTING OF CORONARY SHUNTS FUNCTIONING OF PATIENTS WITH ISCHEMIC HEART TROUBLE IN COMBINATION WITH DIABETES OF 2 TYPE IN REMOTE PERIOD AFTER OPERATION OF AORTOCORONARY SHUNTING | 2007 |
|
RU2336824C1 |
| THERAPEUTIC APPROACH TO PATIENTS SUFFERING ISCHEMIA OF LOWER EXTREMITIES AND MULTIVESSEL DISEASE OF CORONARY BED | 2014 |
|
RU2553429C1 |
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD FOR PREVENTION OF POSTPERICARDIOTOMY SYNDROME IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY BYPASS SURGERY | 2014 |
|
RU2556198C1 |
| METHOD OF DRUG TREATMENT OF PATIENTS IN LATE REHABILITATION PERIOD AFTER AORTOCORONARY BYPASS SURGERY | 2013 |
|
RU2545985C2 |
